Our Therapy Areas

Specialized pharmaceutical solutions across nine key therapeutic areas. We are committed to addressing complex medical challenges through innovation, research, and patient-centric approaches.

Comprehensive Healthcare Solutions

Click on any therapy area to learn more about our specialized treatments and approaches

Diabetes

We offer comprehensive solutions for Type 1 and Type 2 diabetes management, including innovative insulin therapies and oral hypoglycemic agents that help patients maintain optimal blood glucose levels.

463M+ Patients
15+ Products

Cardiovascular Diseases

Our cardiovascular portfolio includes advanced treatments for hypertension, heart failure, arrhythmias, and dyslipidemia, focusing on prevention, management, and improved patient outcomes.

523M+ Patients
12+ Products

Neuropsychiatry

Addressing neurological and psychiatric conditions including depression, anxiety, epilepsy, Parkinson's disease, and Alzheimer's through innovative pharmacological interventions.

1B+ Affected
18+ Products

Gastroenterology

Comprehensive treatments for gastrointestinal disorders including GERD, IBD, IBS, liver diseases, and pancreatic disorders, focusing on improving digestive health and quality of life.

40% Population
10+ Products

Ophthalmology

Specialized treatments for glaucoma, macular degeneration, diabetic retinopathy, dry eye syndrome, and other ocular conditions to preserve and enhance vision.

2.2B+ Affected
8+ Products

Gynaecology

Comprehensive women's healthcare solutions including hormonal therapies, fertility treatments, menopause management, and treatments for gynecological disorders.

3.9B Women
14+ Products

Urology

Treatments for urological conditions including BPH, urinary incontinence, kidney stones, UTIs, and bladder disorders, focusing on improved urinary health and function.

30% Affected
9+ Products

Oncology

Advanced oncology solutions including chemotherapy, targeted therapies, immunotherapies, and supportive care for various cancers, focusing on improved survival and quality of life.

19.3M Cases/yr
7+ Products

Nephrology

Comprehensive renal care including treatments for chronic kidney disease, acute kidney injury, dialysis support, and transplantation medications for improved renal outcomes.

850M Affected
6+ Products

Diabetes Management

Advanced therapies for Type 1 & Type 2 diabetes

Overview

Diabetes is a chronic metabolic disorder characterized by elevated blood glucose levels resulting from defects in insulin production, insulin action, or both. Armedza offers comprehensive solutions for both Type 1 and Type 2 diabetes management.

Our Therapeutic Approaches

  • Insulin Therapies: Long-acting, rapid-acting, and premixed insulin formulations
  • Oral Hypoglycemic Agents: Metformin, sulfonylureas, DPP-4 inhibitors, SGLT2 inhibitors
  • GLP-1 Receptor Agonists: Advanced injectable therapies for improved glycemic control
  • Combination Therapies: Fixed-dose combinations for enhanced efficacy and compliance
  • Supportive Care: Medications for diabetes-related complications
463M+ People with diabetes worldwide
15+ Specialized products
90% Type 2 diabetes cases

Innovation Focus

Our R&D focuses on developing novel drug delivery systems, improving insulin stability, creating glucose-responsive insulin formulations, and exploring regenerative medicine approaches for beta-cell restoration.

Cardiovascular Diseases

Comprehensive cardiac care and prevention

Overview

Cardiovascular diseases remain the leading cause of death globally. Our portfolio addresses the spectrum of cardiac conditions with evidence-based therapies focusing on prevention, management, and improved quality of life.

Therapeutic Areas

  • Hypertension: ACE inhibitors, ARBs, calcium channel blockers, diuretics
  • Heart Failure: Beta-blockers, ARNIs, diuretics, inotropic agents
  • Dyslipidemia: Statins, fibrates, PCSK9 inhibitors, cholesterol absorption inhibitors
  • Arrhythmias: Antiarrhythmic drugs, rate control medications
  • Antiplatelets/Anticoagulants: Prevention of thrombotic events
523M+ People living with CVD
12+ Cardiovascular products
#1 Leading cause of death globally

Preventive Cardiology

We emphasize preventive strategies through lipid management, blood pressure control, and lifestyle modification support. Our research focuses on novel targets for atherosclerosis regression and myocardial protection.

Neuropsychiatry

Advanced treatments for brain and mental health

Overview

Neuropsychiatric disorders represent some of the most challenging conditions in medicine. Our comprehensive portfolio addresses both neurological and psychiatric conditions with innovative therapeutic approaches.

Conditions We Address

  • Psychiatric Disorders: Depression, anxiety, bipolar disorder, schizophrenia
  • Neurological Conditions: Epilepsy, migraine, Parkinson's disease, Alzheimer's
  • Neuropathic Pain: Diabetic neuropathy, post-herpetic neuralgia
  • Sleep Disorders: Insomnia, sleep apnea treatments
  • Movement Disorders: Dystonia, essential tremor therapies
1B+ People affected worldwide
18+ Specialized products
70% Treatment gap in low-income countries

Innovation in Neuropsychiatry

Our research focuses on novel mechanisms including glutamate modulation, neuroinflammation targets, neurotrophic factors, and digital therapeutics. We're exploring precision psychiatry approaches through biomarker development.

Gastroenterology

Digestive health and gastrointestinal care

Overview

Gastrointestinal disorders affect millions worldwide, impacting quality of life and overall health. Our gastroenterology portfolio addresses the full spectrum of digestive disorders with targeted therapeutic solutions.

Key Focus Areas

  • Acid-Related Disorders: GERD, peptic ulcers, gastritis treatments
  • Inflammatory Bowel Disease: Crohn's disease, ulcerative colitis therapies
  • Irritable Bowel Syndrome: Symptom management and motility regulators
  • Liver Diseases: Hepatitis, cirrhosis, fatty liver disease treatments
  • Pancreatic Disorders: Pancreatitis, enzyme replacement therapies
40% Global population affected
10+ Gastroenterology products
3rd Leading cause of cancer deaths

Advanced GI Care

We're pioneering novel approaches including microbiome modulation, targeted anti-inflammatory agents, and advanced drug delivery systems for localized GI treatment. Our research includes developing gut-selective therapies with minimal systemic exposure.

Ophthalmology

Vision preservation and eye health

Overview

Vision is one of our most precious senses, and eye diseases can significantly impact quality of life. Our ophthalmology portfolio focuses on preserving and enhancing vision through advanced therapeutic interventions.

Ocular Conditions Addressed

  • Glaucoma: Intraocular pressure management, neuroprotection
  • Retinal Diseases: AMD, diabetic retinopathy, retinal vein occlusion
  • Ocular Inflammation: Uveitis, conjunctivitis, keratitis treatments
  • Dry Eye Syndrome: Lubricants, anti-inflammatory agents
  • Allergic Conjunctivitis: Mast cell stabilizers, antihistamines
2.2B+ People with vision impairment
8+ Ophthalmology products
80% Visual impairment is preventable

Innovation in Eye Care

Our R&D focuses on sustained-release formulations, novel drug delivery systems (including implants and inserts), gene therapies for inherited retinal diseases, and neuroprotective agents for glaucoma. We're exploring combination therapies that address multiple pathways in ocular diseases.

Gynaecology

Women's health across the lifespan

Overview

Women's health requires specialized attention at every life stage. Our gynaecology portfolio provides comprehensive solutions for reproductive health, hormonal balance, and gynecological conditions affecting women worldwide.

Comprehensive Women's Health

  • Contraception: Oral contraceptives, emergency contraception, long-acting options
  • Fertility Treatments: Ovulation induction, assisted reproduction support
  • Menopause Management: HRT, symptom relief, bone health protection
  • Menstrual Disorders: Dysmenorrhea, menorrhagia, PCOS treatments
  • Gynecological Infections: Bacterial vaginosis, yeast infections, STI treatments
3.9B Women worldwide
14+ Women's health products
1 in 10 Women affected by endometriosis

Advancing Women's Healthcare

We're developing novel hormone therapies with improved safety profiles, targeted treatments for endometriosis and uterine fibroids, and personalized medicine approaches based on genetic and hormonal profiling. Our research includes non-hormonal options for contraception and menopause management.

Urology

Urinary and male reproductive health

Overview

Urological conditions affect urinary function and male reproductive health, significantly impacting quality of life. Our urology portfolio provides targeted solutions for a wide range of urinary tract and male reproductive system disorders.

Key Urological Areas

  • Benign Prostatic Hyperplasia: Alpha-blockers, 5-alpha reductase inhibitors
  • Overactive Bladder: Antimuscarinics, beta-3 agonists
  • Urinary Incontinence: Stress and urge incontinence treatments
  • Urinary Tract Infections: Antibiotics, prophylaxis, recurrent UTI management
  • Erectile Dysfunction: PDE5 inhibitors, hormonal therapies
30% Men over 50 have BPH symptoms
9+ Urology products
50% Women experience UTIs in lifetime

Innovation in Urological Care

Our research includes novel mechanisms for bladder control, minimally invasive drug delivery systems, combination therapies for BPH, and treatments for interstitial cystitis. We're exploring gene therapies for inherited urological conditions and developing personalized approaches based on urinary biomarkers.

Oncology

Advanced cancer care and therapies

Overview

Cancer remains one of the most challenging areas of medicine. Our oncology portfolio includes innovative therapies that target cancer cells while minimizing impact on healthy tissues, focusing on improved survival and quality of life for cancer patients.

Comprehensive Cancer Care

  • Chemotherapy: Traditional cytotoxic agents with improved safety profiles
  • Targeted Therapies: Small molecules targeting specific cancer pathways
  • Immuno-oncology: Checkpoint inhibitors, cancer vaccines, CAR-T support
  • Hormonal Therapies: Breast and prostate cancer treatments
  • Supportive Care: Anti-emetics, growth factors, pain management
19.3M New cancer cases annually
7+ Oncology products
70% Cancer deaths in low/middle-income countries

Next-Generation Oncology

Our R&D focuses on precision medicine approaches, biomarker-driven therapies, antibody-drug conjugates, and novel immunotherapies. We're developing combination regimens that target multiple cancer pathways simultaneously and exploring liquid biopsy technologies for early detection and monitoring.

Nephrology

Kidney health and renal care

Overview

Kidney diseases represent a growing global health burden with significant morbidity and mortality. Our nephrology portfolio provides comprehensive solutions for renal disorders, focusing on slowing disease progression and improving patient outcomes.

Renal Care Focus Areas

  • Chronic Kidney Disease: Slowing progression, managing complications
  • Diabetic Nephropathy: Renoprotective agents for diabetes patients
  • Hypertensive Nephropathy: Blood pressure control with renal protection
  • Acute Kidney Injury: Supportive care and recovery enhancement
  • Dialysis Support: Medications for dialysis patients, mineral bone disorder
850M People with kidney diseases
6+ Nephrology products
5-10M Annual deaths from kidney diseases

Innovation in Renal Care

We're developing novel anti-fibrotic agents, targeted therapies for glomerular diseases, and combination approaches that address multiple pathways in kidney disease progression. Our research includes regenerative medicine approaches for kidney repair and developing biomarkers for early detection and monitoring of renal diseases.